Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andrea M. Binnebose"'
Autor:
Andrea M. Binnebose, Adam S. Mullis, Shannon L. Haughney, Balaji Narasimhan, Bryan H. Bellaire
Publikováno v:
Frontiers in Antibiotics, Vol 2 (2023)
Mycobacterium marinum is a waterborne pathogen responsible for tuberculosis-like infections in cold-blooded animals and is an opportunistic pathogen in humans. M. marinum is the closest genetic relative of the Mycobacterium tuberculosis complex and i
Externí odkaz:
https://doaj.org/article/a0405e01d212498d85e8dcb1c086db05
Autor:
Andrea M Binnebose, Shannon L Haughney, Richard Martin, Paula M Imerman, Balaji Narasimhan, Bryan H Bellaire
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 10, p e0004173 (2015)
Filarial diseases represent a significant social and economic burden to over 120 million people worldwide and are caused by endoparasites that require the presence of symbiotic bacteria of the genus Wolbachia for fertility and viability of the host p
Externí odkaz:
https://doaj.org/article/948d5f5acc5c4cfe82e078d67de64a18
Autor:
Adam S. Mullis, Scott Broderick, Krishna Rajan, Bryan H. Bellaire, Nathan Peroutka-Bigus, Andrea M. Binnebose, Balaji Narasimhan
Publikováno v:
Molecular pharmaceutics. 16(5)
Drug delivery vehicles can improve the functional efficacy of existing antimicrobial therapies by improving biodistribution and targeting. A critical property of such nanomedicine formulations is their ability to control the release kinetics of their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d3dbf9f74fa8241911702f6bfcbdd2f
https://pubmed.ncbi.nlm.nih.gov/30973741
https://pubmed.ncbi.nlm.nih.gov/30973741
Autor:
Nathan Peroutka-Bigus, Paul Lueth, Adam S. Mullis, Bryan H. Bellaire, Balaji Narasimhan, Andrea M. Binnebose, Shannon L. Haughney
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 294
New therapies are needed to treat chronic bacterial diseases and intracellular pathogens, in particular, are very difficult to manage. The use of nanotherapeutics represents an approach to exploit size and charge of biological membranes to overcome b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::597d1c43fdeacfb05df6aa617f393bfa
https://pubmed.ncbi.nlm.nih.gov/30572034
https://pubmed.ncbi.nlm.nih.gov/30572034
Autor:
Shannon L. Haughney, Richard J. Martin, Andrea M. Binnebose, Bryan H. Bellaire, Balaji Narasimhan, Paula M. Imerman
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 9, Iss 10, p e0004173 (2015)
PLoS Neglected Tropical Diseases, Vol 9, Iss 10, p e0004173 (2015)
Filarial diseases represent a significant social and economic burden to over 120 million people worldwide and are caused by endoparasites that require the presence of symbiotic bacteria of the genus Wolbachia for fertility and viability of the host p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63420009f1f2e51aad7a8dbbb2d5f5d3
http://europepmc.org/articles/PMC4619673
http://europepmc.org/articles/PMC4619673
Autor:
Yashdeep Phanse, Bryan H. Bellaire, Kathleen A. Ross, Timothy M. Brenza, Andrea M. Binnebose, Lyric C. Bartholomay, Aliasger K. Salem, Anumantha G. Kanthasamy, Howard E. Gendelman, Balaji Narasimhan
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 219
Complex biological barriers are major obstacles for preventing and treating disease. Nano-carriers are designed to overcome such obstacles by enhancing drug delivery through physiochemical barriers and improving therapeutic indices. This review criti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39d7e82492bf12a6735a01cd137e09c8
https://pubmed.ncbi.nlm.nih.gov/26315817
https://pubmed.ncbi.nlm.nih.gov/26315817